Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 18/20 | 0.42 |
| ▸ | CYP11B1 | P15538 | 17/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21397039 | 0.92 | CYP11B2 (0.45) | CYP11B2CYP11B1KDM4EATML3MBTL1 | |
| SCHEMBL21397006 | 0.85 | CYP11B1 (0.39) | CYP11B2CYP11B1ALDH1A1NPSR1TDP1 | |
| SCHEMBL19062209 | 0.85 | IMPDH2 (0.43) | ALDH1A1NPSR1TDP1KDM4EATM | |
| SCHEMBL21396647 | 0.84 | CYP11B2 (0.38) | CYP11B2CYP11B1ALDH1A1NPSR1KDM4E | |
| SCHEMBL21396649 | 0.84 | CYP11B2 (0.36) | CYP11B2CYP11B1ALDH1A1NPSR1TDP1 | |
| SCHEMBL21397073 | 0.83 | CYP11B1 (0.41) | CYP11B2CYP11B1ALDH1A1NPSR1TDP1 | |
| SCHEMBL21396951 | 0.82 | SMN1; SMN2 (0.35) | CYP11B2CYP11B1ALDH1A1KDM4EATM | |
| SCHEMBL612850 | 0.82 | KDM4E (0.52) | CYP11B2CYP11B1KDM4EATML3MBTL1 | |
| SCHEMBL19697237 | 0.82 | KDM4E (0.41) | CYP11B2CYP11B1ALDH1A1NPSR1TDP1 | |
| SCHEMBL19037891 | 0.80 | L3MBTL1 (0.50) | ALDH1A1NPSR1TDP1KDM4EATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3543230-B1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO LTD (KR) | 2021-05-05 | — | — | EP | disclosed |
| US-20190296247-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190296247-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SLC25A21, SLCO4C1, SLC18A1 | CYP11B2 1859/4885CYP11B1 1877/4885ALDH1A1 825/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.